Vardhman Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 24.34 Cr
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 175.00 Cr
- Revenue Growth -65.83%
- Profit Growth -79.52%
- Ebitda 17.11%
- Net Worth -105.37%
- Total Assets -17.31%
About Vardhman Life Sciences
Vardhman Life Sciences Private Limited (VLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 December 2007 and has a history of 17 years and two months. Its registered office is in Delhi, India.
The Corporate was formerly known as Dewan Buildcon Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 24.34 Cr.
The company currently has active open charges totaling ₹175.00 Cr.
Vivek Gupta, Rajinder Gujral, and Suyog Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230DL2007PTC171395
- Company No.
171395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2007
- Date of AGM
21 Mar 2017
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vardhman Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Gupta  | Director | 20-Apr-2010 | Current |
| Rajinder Gujral | Director | 20-Apr-2010 | Current |
| Suyog Jain | Director | 20-Apr-2010 | Current |
Financial Performance of Vardhman Life Sciences.
Vardhman Life Sciences Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 65.83% decrease. The company also saw a substantial fall in profitability, with a 79.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 105.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vardhman Life Sciences?
In 2015, Vardhman Life Sciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹175.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Edelweiss Asset Reconstruction Company Limited : 120.00 Cr
- Others : 55.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2010 | Edelweiss Asset Reconstruction Company Limited | ₹40.00 Cr | Open |
| 15 Dec 2010 | Edelweiss Asset Reconstruction Company Limited | ₹40.00 Cr | Open |
| 23 Nov 2010 | Edelweiss Asset Reconstruction Company Limited | ₹40.00 Cr | Open |
| 29 Oct 2010 | Others | ₹55.00 Cr | Open |
How Many Employees Work at Vardhman Life Sciences?
Vardhman Life Sciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vardhman Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhman Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
